跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTAMONE F.C. TABLET 10 MG - HSA Drug Approval Details
Approvals
/
HSA
/
ACTAMONE F.C. TABLET 10 MG
Approved
THERAPEUTIC
ACTAMONE F.C. TABLET 10 MG
Actavis Ltd.
🇸🇬 Health Sciences Authority
Approval Date
May 25, 2016
Approval ID
c1c5df5980ddf89a
Company
Actavis Ltd.
Type
Therapeutic
Approval Details
Approval Id
c1c5df5980ddf89a
Drug Name
ACTAMONE F.C. TABLET 10 MG
Product Name
ACTAMONE F.C. TABLET 10 MG
Approval Number
SIN15017P
Approval Date
2016-05-25
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Montelukast Sodium 10.40mg equivalent to Montelukast
10.00 mg
MONTELUKAST SODIUM 10.4 MG EQUIVALENT TO MONTELUKAST
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 25, 2016
Approval ID
c1c5df5980ddf89a
Type
Therapeutic
Back to HSA Approvals